Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for CAPA (Corrective and Preventive Actions) Management

Posted on By

SOP for CAPA (Corrective and Preventive Actions) Management

Standard Operating Procedure for Corrective and Preventive Actions

1) Purpose

The purpose of this SOP is to establish procedures for identifying, documenting, investigating, and implementing corrective and preventive actions (CAPAs) to address deviations, non-conformances, and potential issues within the pharmaceutical manufacturing processes.

2) Scope

This SOP applies to all personnel responsible for initiating, managing, and closing CAPAs within the pharmaceutical manufacturing facility.

3) Responsibilities

3.1 Quality Assurance (QA) Team

  • Oversee CAPA process and ensure compliance with SOP.
  • Approve CAPA plans and verify effectiveness of actions.

3.2 Manufacturing and Quality Control (QC) Teams

  • Initiate CAPA requests and provide necessary documentation.
  • Implement CAPA actions within specified timelines.
See also  SOP for Gowning and Degowning Procedures

4) Procedure

4.1 CAPA Initiation

  1. Identify deviation or non-conformance requiring CAPA.
  2. Document CAPA request with details of issue, root cause analysis, and proposed actions.

4.2 CAPA Investigation

  1. Conduct thorough investigation to determine root cause(s) of the issue.
  2. Perform risk assessment to evaluate impact and severity.

4.3 CAPA Plan Development

  1. Develop CAPA plan outlining corrective and preventive actions.
  2. Assign responsibilities and establish timelines for implementation.

4.4 CAPA Implementation

  1. Implement identified corrective actions to address immediate issues.
  2. Implement preventive actions to prevent recurrence of the issue.

4.5 CAPA Effectiveness Review

  1. Monitor and verify effectiveness of implemented CAPA actions.
  2. Close CAPA after confirming resolution and preventive measures.
See also  Injectables: SOP for Sterility Testing

5) Abbreviations, if any

SOP: Standard Operating Procedure; CAPA: Corrective and Preventive Actions; QA: Quality Assurance; QC: Quality Control

6) Documents, if any

  • CAPA Request Form
  • Root Cause Analysis Report
  • CAPA Plan and Implementation Records

7) Reference, if any

ICH Q10: Pharmaceutical Quality System
FDA Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: SOP for Change Control in Aerosol Production
Next Post: SOP for Formulation Development Comparative Evaluation Studies

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version